Navigation Links
Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
Date:7/25/2008

PLEASANTON, Calif., July 25 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR) a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter and first six months of fiscal 2008 on Thursday, July 31.

The company will hold a conference call to discuss its financial results and operating activities to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Thursday, July 31, hosted by Gary F. Burbach, president and chief executive officer, and David Smith, executive vice president and chief financial officer.

The teleconference can be accessed by calling (913) 312-0379, passcode 4566478. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://phx.corporate- ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=1890100 or at http://www.thoratec.com

A replay of the conference call will be available through Thursday, August 7, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 4566478.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate (R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com


'/>"/>
SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
2. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. Thoratecs ITC Division Receives FDA Warning Letter
5. Thoratec Schedules Third Quarter Conference Call, Webcast
6. AMICAS Schedules Second Quarter Earnings Call
7. Mylan Schedules Financial Results Conference Call and Live Webcast for the Second Quarter Fiscal 2008
8. Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 31, 2008
9. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
10. Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call
11. Immucor Schedules Fiscal 2009 Guidance Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: